Kirby I. Bland MD

Kirby I. Bland, MD, is an internationally renowned surgical oncologist with over 40 years dedicated to treating breast cancer patients and advancing cancer research at the University of Alabama at Birmingham (UAB). He has been instrumental in developing innovative treatments like the chemotherapeutic retinoid drug UAB-30 for breast cancer chemoprevention, working with UAB teams at the Kirklin Clinic.[1][4] Recognized as a leading specialist, researcher, and editor in surgical oncology.[3][4]